Here are five facts:
1. The shares had a 6 percent decrease in trading volume from the previous session’s volume of 87,502 shares.
2. Zacks analysts upgraded the shares from a “hold” rating to a “buy” rating on Nov. 30.
3. The market cap is approximately $740.6 million.
4. Orthofix has a 50-day moving average of $39.42.
5. The 200-day moving average is $36.15.
More articles on orthopedics:
Dr. Mark Mudano opens office at Effingham Health System: 3 points
High risk of wrist tendonitis for new parents — 4 things to know
Distracted walking causes more injuries and hospital visits — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.